March 2018 - Page 4 of 22

MondayMar 26, 2018 12:23 pm

BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF) Raising Investments, Awareness and Enrollment in Clinical Trials

Using a proprietary technology platform in development of immunotherapy treatments to fight cancer Company recently announced proposed investment by leading biotech funds and concurrent non-brokered financing for combined gross proceeds of up to $4.8 million Using social media to raise awareness and expand patient recruitment for Bria-IMT™ clinical trials BriaCell Therapeutics Corp. (TSX.V: BCT) (OTCQB: BCTXF) is an immune-oncology biotechnology company developing immunotherapy treatments for cancer through a process which uses the body’s own immune system to destroy cancer cells, creating a safer and more manageable treatment than those previously available. BriaCell is dedicated to enhancing the lives of individuals…

MondayMar 26, 2018 12:00 pm

First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Primed to Capitalize on Rising Demand for Ethical Cobalt

Cobalt prices more than doubled in 2017, with battery production driving demand Global cobalt supply shortage likely brewing with world’s increasing shift to electric vehicles Concerns continue over illegal cobalt mining operations and child labor in geopolitically unstable Democratic Republic of the Congo The world’s appetite for electric vehicles and battery-driven mobile technologies appears to be insatiable, and this demand could generate cobalt supply problems in the not-too-distant future (http://ibn.fm/7RvYJ). Several of the world’s biggest auto companies and tech giants are reportedly looking to bank vast amounts of the metallic element in a bid to secure long-term cobalt supplies (http://ibn.fm/rASCW). First…

MondayMar 26, 2018 10:20 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Set to Provide Business Updates While Sponsoring at the 2018 NIBA Meeting

Market analysis company ChineseInvestors.com (OTCQB: CIIX) this morning said it will sponsor at the 2018 National Investment Bankers Association ("NIBA") meeting in New York City at the Westin Hotel in Times Square on March 27, 2018. Warren Wang, the company’s CEO, will provide a video interview highlighting the company's business updates that will be available for viewing on NIBA's website. The video interview will include details regarding the company’s new cryptocurrency focused website, its recently entered partnership with Phoenix North America Chinese Channel, and its strategy regarding the company's investor relations service which aims to meet specific marketing objectives. "CIIX…

MondayMar 26, 2018 10:01 am

QualityStocksNewsBreaks – PotNetwork Holding, Inc. (POTN) Subsidiary’s MediPets Line Garners Interest at the Global Pet Expo

PotNetwork Holding, Inc. (OTC: POTN), through wholly owned subsidiary Diamond CBD, Inc., this morning announced promising results related to its attendance at the 2018 Global Pet Expo in Orlando, Florida. In total, the company estimates that it garnered interest from over 200 new wholesale distributors that are well suited to carry its groundbreaking CBD-for-pets product line, MediPets. “Our new MediPets line is specifically designed to manage a wide variety of symptoms in their pets with reportedly effective, non-toxic, hemp-derived cannabinoids,” Richard Goulding, CEO of PotNetwork Holding, stated in the news release. “We are pleased to be experiencing this level of…

MondayMar 26, 2018 9:55 am

QualityStocksNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQB: FTSSF) Reports Positive First Assay Results in Cobalt North, Discovers Potential 100 Meter Zone

First Cobalt (TSX.V: FCC) (OTCQB: FTSSF) this morning announced positive assay results from the first drill holes located near the Kerr Mine in the Cobalt North area of the Cobalt Camp in Ontario, Canada. The results presented a potential zone of cobalt mineralization that can be tracked across more than 100 meters. Assays are currently pending for three additional holes. "Indications of both disseminated and vein styles of mineralization across a network for more than 100 meters make this an attractive target for a future bulk tonnage operation. With zones of mineralization now identified in Cobalt South and Cobalt North,…

FridayMar 23, 2018 12:29 pm

AnalytixInsight Inc. (TSX.V: ALY) (OTCQB: ATIXF) Portal Makes Quant Research Tools Available to Individual Investors

Financial portal offering quant tools to small investors Reports on over 50,000 global equities and North American ETFs Financial news from Euronext, The Wall Street Journal, Thomson Reuters, Yahoo Finance, et al Overpowered by the rise of the machines in the financial markets, individual stock pickers have retreated. A recent report from JP Morgan estimates that just 10 percent of trading volume today can be attributed to fundamental discretionary traders (http://ibn.fm/JRVgb). Deploying powerful algorithmic strategies, institutional investors have routed small investors and driven them from the field. The decimation of the individual investor community has been relatively rapid. “50 years…

FridayMar 23, 2018 12:16 pm

QualityStocksNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Capitalizing on the Vast Market Potential of Hemp, CBD Products

Hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) remains primarily focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets. An article discussing the company reads: “Founded in 2014, Global Hemp Group is building a strategic portfolio of hemp-based companies to provide its global customer base with a consistent supply of high-quality hemp-derived products. It intends to leverage the huge market potential of hemp products to deliver significant ROI to its shareholders. The number of products that can be manufactured from the hemp plant is vast. It can be used to…

FridayMar 23, 2018 12:09 pm

QualityStocksNewsBreaks – Marijuana Company of America, Inc. (MCOA) Offers a Natural Option for Pet Owners with hempSMART Full Spectrum Pet Drops

Innovative hemp and cannabis corporation Marijuana Company of America (OTC: MCOA) recently launched its new CBD-based natural pet product, hempSMART™ Full Spectrum Pet Drops. An article discussing the company’s new pet product line reads: “MCOA’s hempSMART™ Full Spectrum Pet Drops for cats and dogs are formulated with 250mg of full spectrum non-psychoactive cannabidiol (CBD) derived from industrial hemp. The new, specially-formulated product contains naturally-occurring CBD derived from hemp seed oil, full spectrum hemp extract, fractionated coconut oil and a rich bacon flavor that pets will love. The new Full Spectrum Pet Drops add a new vertical to MCOA’s fast growing…

FridayMar 23, 2018 11:41 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Helping Smokers Light Up Less

Poised to revolutionize smokeless tobacco Proven effective in cannabinoid delivery, undergoing testing for nicotine An enabling tech seeking third-party partnerships within the tobacco industry Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is helping smokers light up less. Using LXRP’s revolutionary technology, smokers could be able to give up smoking without giving up nicotine. With one billion smokers worldwide, companies are seeking safer delivery technologies to help wean smokers from this deadly habit. Through third-party partnerships with major tobacco industry players, LXRP is poised to revolutionize smokeless tobacco (http://ibn.fm/2iqhO). Lexaria is gaining prominence for its proprietary delivery technology. The company’s DehydraTECH™…

FridayMar 23, 2018 11:22 am

QualityStocksNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Technology Mimics the Body’s Natural Creation of Pain Fighting Peptides

Health sciences company PreveCeutical Medical (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is engaged in the development of pain relievers that mimic body’s natural pain relief peptides. An article discussing the company reads: “The linker technology that underlies PreveCeutical’s drug development platform was developed at the University of Queensland in Australia. At that impressive institution, Dr. Parekh headed a team that developed synthetic molecules capable of mimicking the endomorphins produced by the body for pain relief, as explained by PreveCeutical chairman and CEO Stephen Van Deventer in a recent video interview (http://ibn.fm/XL19u). Although they are as potent as morphine, the effect…

Site Search

Company Search

Month: March 2018